|
|
|
| home > white papers > How To Increase Efficiency, Customer Satisfaction and Reduce Cost - AC Labels |
|
|
 WHITE PAPERS |
|
|
AC Labels
|
|
How To Increase Efficiency, Customer Satisfaction and Reduce Cost
|
|
A customer of Riverside Medical had required a complex four-part 'piggy back' label. The labels needed to be specially constructed to facilitate removal in parts at various stages of its use for quality control traceability. This label needed to carry variable data elements of LOT numbers, batch numbers and product descriptions, and also a secondary gamma indicator label placed on each of its 4 sections to prove its sterility following sterilisation.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Sygnature Discovery Creates 2nd Integrated Drug Discovery Site At Alderley Park
Sygnature Discovery, a
world-leading integrated drug discovery and non-clinical solutions provider,
has begun expanding into new state of the art laboratories at Bruntwood
SciTech’s Alderley Park, Cheshire, adding Chemistry and Biology expertise to
its DMPK and Translational Oncology teams already present on the site.
More info >> |
|
 |
White Papers |
 |
|
R&D to Product: How to Reduce Costly Scale-Up Problems
Natoli Engineering Company, Inc.
When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >> |
|
 |
Industry Events |
 |
DIA Europe 2021
15-19 March 2021, VIRTUAL CONFERENCE
DIA Europe is the must-attend event for all life science professionals
working in drug development, from discovery to marketed use. It
encourages open collaboration by bringing together representatives from
the entire spectrum of the life science landscape and facilitating
crucial discussions across several topic tracks: Clinical Development,
Regulatory Strategy, Pharmacovigilance, Value and Access, Health Policy,
and many more.
More info >> |
|
|
|
